Sixty-seven adults with idiopathic membranous nephropathy and the nephrotic syndrome were randomly assigned to symptomatic treatment only or to a six-month course of methylprednisolone alternated with chlorambucil every other month. Patients were followed for one to seven years. At the end of follow-up (mean of 31.4 +/- 18.2 months for the treated group and 37.0 +/- 22.0 for the control group) 23 of 32 treated patients were in complete or partial remission, as compared with 9 of 30 control patients (P = 0.001). Twelve of the treated patients were in complete remission, as compared with only two of the controls. In the treated group there were no changes in renal function during follow-up, whereas in the control group the reciprocal of the plasma creatinin level, which is proportional to the creatinine clearance, decreased significantly (P = 0.00017) after two years of follow-up. Side effects were minimal in all treated patients except two, who were dropped from the study because of peptic ulcer and gastric intolerance to chlorambucil. We conclude that steroid and chlorambucil treatment for six months favors remission of the nephrotic syndrome in adults with idiopathic membranous nephropathy and can preserve renal function for at least some years.
This article has been cited by other articles:
Fervenza, F. C., Sethi, S., Specks, U.
(2008). Idiopathic Membranous Nephropathy: Diagnosis and Treatment. CJASN
3: 905-919
[Abstract][Full Text]
Glassock, R. J.
(2007). Prophylactic Anticoagulation in Nephrotic Syndrome: A Clinical Conundrum. J. Am. Soc. Nephrol.
18: 2221-2225
[Abstract][Full Text]
Musante, L., Candiano, G., Petretto, A., Bruschi, M., Dimasi, N., Caridi, G., Pavone, B., Del Boccio, P., Galliano, M., Urbani, A., Scolari, F., Vincenti, F., Ghiggeri, G. M.
(2007). Active Focal Segmental Glomerulosclerosis Is Associated with Massive Oxidation of Plasma Albumin. J. Am. Soc. Nephrol.
18: 799-810
[Abstract][Full Text]
Tse, K C, Lam, M F, Tang, S C., Tang, C S., Chan, T M
(2007). A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade. Lupus
16: 46-51
[Abstract]
Wang, A Y., Li, P K., Lai, F M., Chow, K M, Szeto, C C, Leung, C B, Lui, S F
(2001). Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in Chinese. Lupus
10: 295-298
[Abstract]
Hallegua, D, Wallace, D J, Metzger, A L, Rinaldi, R Z, Klinenberg, J R
(2000). Cyclosporine for lupus membranous nephritis:experience with ten patients and review of the literature. Lupus
9: 241-251
[Abstract]
NEUGARTEN, J., ACHARYA, A., SILBIGER, S. R.
(2000). Effect of Gender on the Progression of Nondiabetic Renal Disease: AMeta-Analysis. J. Am. Soc. Nephrol.
11: 319-329
[Abstract][Full Text]
Mason, P D, Pusey, C D
(1994). Fortnightly Review: Glomerulonephritis: diagnosis and treatment. BMJ
309: 1557-1563
[Abstract][Full Text]
Schieppati, A., Mosconi, L., Perna, A., Mecca, G., Bertani, T., Garattini, S., Remuzzi, G.
(1993). Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy. NEJM
329: 85-89
[Abstract][Full Text]
Besbas, N., Topaloglu, R., Saatci, O., Bakkaloglu, A.
(1992). Long-Term Follow-Up in Children with Steroid-Resistant Nephrotic Syndrome. CLIN PEDIATR
31: 283-288
[Abstract]
Previous
